| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910828846903321 |
|
|
Titolo |
Ranking vaccines . Phase III Use case studies and data framework : applications of a prioritization software tool / / Institute of Medicine and National Academy of Engineering of the National Academies |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Washington, District of Columbia : , : The National Academies Press, , 2015 |
|
©2015 |
|
|
|
|
|
|
|
|
|
ISBN |
|
0-309-30406-7 |
0-309-30404-0 |
|
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (128 p.) |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Drugs - Design |
Vaccines - United States |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references. |
|
|
|
|
|
|
Nota di contenuto |
|
""Front Matter""; ""Reviewers""; ""Preface""; ""Contents""; ""Disclaimer""; ""Summary""; ""1 Introduction: SMART Vaccines and Smart Priorities""; ""2 Data Synthesis and Framework""; ""3 Use Case Scenarios and Design Enhancements""; ""4 Reflections and Looking Forward""; ""References""; ""Appendix A: Use Case Scenarios Report for SMART Vaccines""; ""Appendix B: Committee's Response to the Use Case Scenarios Report""; ""Appendix C: SMART Vaccines Software Updates""; ""Appendix D: Stakeholder Speakers""; ""Appendix E: Biographical Information"" |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
"SMART Vaccines - Strategic Multi-Attribute Ranking Tool for Vaccines - is a prioritization software tool developed by the Institute of Medicine that utilizes decision science and modeling to help inform choices among candidates for new vaccine development. A blueprint for this computer-based guide was presented in the 2012 report Ranking Vaccines: A Prioritization Framework: Phase I. The 2013 Phase II report refined a beta version of the model developed in the Phase I report. Ranking Vaccines: Applications of a Prioritization Software Tool: Phase III: Use Case Studies and Data Framework extends this project by demonstrating the practical applications of SMART Vaccines through |
|
|
|
|
|
|
|
|
|
|
|
|
|
use case scenarios in partnership with the Public Health Agency of Canada, New York State Department of Health, and the Serum Institute of India. This report also explores a novel application of SMART Vaccines in determining new vaccine product profiles, and offers practical strategies for data synthesis and estimation to encourage the broader use of the software." -- |
|
|
|
|
|
|
2. |
Record Nr. |
UNINA9911019834503321 |
|
|
Titolo |
Corporate boards : managers of risk, sources of risk / / edited by Robert W. Kolb and Donald Schwartz |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Chichester ; ; Malden, MA, : Wiley-Blackwell, 2009 |
|
|
|
|
|
|
|
ISBN |
|
9786612292033 |
9781282292031 |
128229203X |
9781444315882 |
1444315889 |
9781444315899 |
1444315897 |
|
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (xiv, 379 pages) : illustrations |
|
|
|
|
|
|
Collana |
|
Loyola University series on risk |
|
|
|
|
|
|
Altri autori (Persone) |
|
KolbRobert W. <1949-> |
SchwartzDonald E. <1930-> |
|
|
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
|
|
Soggetti |
|
Boards of directors |
Corporate governance |
Risk management |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references and index. |
|
|
|
|
|
|
Nota di contenuto |
|
CORPORATE BOARDS; Contents; Notes on Contributors; Preface; Introduction; Part I A Factual Basis; 1 The Relationship Between Boards of Directors and their Risk Management Organizations: Are Standards of Best Practice Emerging?; Part II Is Risk Management by Corporate |
|
|
|
|
|
|
|
|
|
|
|
Boards Even Possible?; 2 Risk Management, Chaos Theory, and the Corporate Board of Directors; 3 Anti-Social Norms, Risky Behavior; 4 Time-Inconsistent Boards and the Risk of Repeated Misconduct; 5 Discussion; Part III Board Structure and the Management of Risk; 6 Theories of Governance and Corporate Moral Vulnerability |
7 Mitigating the Exposure of Corporate Boards to Risk and Unethical Conflicts8 Supervisory Board and Financial Risk-Taking Behaviors in Chinese Listed Companies; 9 Discussion; Part IV Corporate Boards and the Management of Specific Risks; 10 Entity-Level Controls and the Monitoring Role of Corporate Boards; 11 Do Corporate Boards Care About Sustainability? Should They Care?; 12 Executive Risk Taking and Equity Compensation in the M&A Process; 13 Discussion; Part V Corporate Boards, Risk Management, and the Ethical Firm; 14 The Ethics of Risk Management by a Board of Directors |
15 Assurance and Reassurance: The Role of the Board16 Risk Disclosure and Transparency: Toward Corporate Collective and Collaborative Informed Consent; 17 Discussion; Index |
|
|
|
|
|
|
Sommario/riassunto |
|
Corporate Boards: Managers of Risk, Sources of Risk deals with the highly timely topic of the Corporate Board and its relationship to risk, both in terms of its management and its creation. Utilizes a multi-disciplinary perspective which draws on the fields of economics, law, business ethics, and corporate social responsibilityFeatures a range of topics including the role of corporate boards in overseeing increasingly complex risk management techniques and the ethical dimensions of corporate board behavior in managing risk Of interest to students, scholar |
|
|
|
|
|
|
|
| |